- Worldwide Rank #10,202,488
- Follower/Following Ratio 0.63
- Daily New Followers 0
治験ナビ Twitter Stats
@02chiken - Tracking 治験ナビ Twitter profile since August 24, 2012
・ 新しい『薬』を開発するためには『薬の候補物質（新しいお薬）』について、 人での『有効性』と『安全性』を確認するため、『臨床試験』が必要になります。 この、厚生労働省から『薬』として承認を受けるために行う臨床試験のことを 『治験』と呼んでいます。
治験ナビ, also known as @02chiken has a reasonably significant presence on Twitter and is ranked by us in the 40% percentile for account strength. Active on Twitter since June 2012, 治験ナビ made it to having a respectable 1,140 Twitter followers and to being ranked 10,202,488 for number of followers among all Twitter users.
Uh-oh... seems like someone has fallen asleep while on duty and is dropping in social relevance. The plot thickens when considering 治験ナビ's follower-to-following ratio, which is 0.63. This actually doesn't reflect so well on this account's strength.
Tweeting is apparently one of @02chiken's favorite pastimes, with an average of 0 tweet(s) per day in the past 30 days. That's pretty consistent with a total of 1,811 since @02chiken joined Twitter.
This account is tracked by us for quite some time now, actually since August 2012. As of June 25 2018 we track 289804494 Twitter accounts, so feel free to search for other accounts you're interested in and reveal their Twitter story!
@02chiken has posted 0 tweets in the last 27 days, which translates to an average of 0 tweets per day.
治験ナビ Twitter Followers
@02chiken has 1,140 followers on Twitter.
This account is #10,202,488 in the worldwide rank of the most popular Twitter users.
治験ナビ Following on Twitter
@02chiken is following 1,824 Twitter accounts.
Last month this account followed 1,647 users.
治験ナビ Predictions & Milestones
@02chiken will hit 1,140 followers in the next 3 months, and 1,140 in one year.
You are on 治験ナビ's Twitter stats page
We track these Twitter stats since August 24, 2012 . You can see how many followers 治験ナビ lost or gained and what the prediction is for tomorrow or the next 15 days, together with all kinds of other stats like rank compared to all Twitter users, tweets etc.